Delivery Order SPE2DB20D2104-SPE2DB24FU06Q
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,627.55, is for the delivery of Bromfenac Sodium 0.09% eye drops. This is a firm fixed-price delivery order contract with a completion date of November 25, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,383.81 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This $38,872.30 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,911,110 units of Bromfenac Sodium 0.09% Eye Drops, 1.7 ml, to be delivered by November 28, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% Eye Drops (1.7 mL) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,447.52, has an ultimate completion date of October 16, 2024. This award is not designated as a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product, with a ceiling value of $2,443.08. The contract is a firm fixed-price delivery order that runs through April 2025. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $4,236.38 firm fixed-price contract is for the supply of 4565951611 - Bromfenac Sodium 0.09% Eye Drops in 1.7 milliliter containers. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization and holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop...
- This federal contract award, valued at $1,517.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $5,626.85 firm fixed price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a completion date of March 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,388.91, is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a Delivery Order, with a Firm Fixed Price pricing type and an ultimate completion date of October 26, 2023. The contract was awarded on October 25, 2023 and does not have a...
- This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bromfenac Sodium 0.09% eye drops. The contract is valued at $3,011.19 and has a firm fixed price pricing type. The ultimate completion date for this order is February 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FU06QDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.68 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a performance period ending on May 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 5/7/24 |